Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Loprinzi

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2022
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in EuropeI Vaz-Luis, M Masiero, G Cavaletti, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2022
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in EuropeI Vaz-Luis, M Masiero, G Cavaletti, et al.
Pageof 2